.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Baxter
Cantor Fitzgerald
Julphar
Johnson and Johnson
Moodys
Mallinckrodt
US Army
Fish and Richardson
Healthtrust

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Somatostatin analogs
Abstract:This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention also specifically relates to cyclic peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (.sup.186 Re) and rhenium-188 (.sup.188 Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provided.
Inventor(s): Dean; Richard T. (Bedford, NH)
Assignee: Diatide, Inc. (Londonderry, NH)
Filing Date:Oct 19, 1999
Application Number:09/420,865
Claims:1. A somatostatin receptor-binding peptide having a formula:

wherein

B.sup.1 is D- or L-Phe or D- or L-Tyr or D- or L-Nal or Ain;

B.sup.2 is D- or L-Trp;

B.sup.3 is D- or L-Lys or Hly, Achxa, Amf, Aec, Apc, Aes, or Aps;

B.sup.4 is Thr, Ser, Val, Phe, Ile, Abu, Nle, Leu, Nva or Aib;

C.sup.4 is an L-amino acid having a sidechain comprising a mercapto group;

A.sup.4 is a lipophilic D-amino acid or a lipophilic L-(.alpha.-N-alkyl)amino acid or L-proline;

wherein A.sup.4 and C.sup.4 are covalently linked through an amino terminus of A.sup.4 and a carboxyl terminus of C.sup.4.

2. The peptide of claim 1, wherein B.sup.1 is phenylalanine or tyrosine, B.sup.2 is D-tryptophan, B.sup.3 is lysine and B.sup.4 is threonine or valine.

3. The peptide of claim 1, further comprising a radioisotope selected from the group consisting of iodine-123, iodine-125, iodine-131, and astatine-211.

4. A multimer having a molecular weight of less than about 20,000 daltons comprising:

a) at least two somatostatin receptor-binding peptides, each having a formula:

wherein

B.sup.1 is D- or L-Phe or D- or L-Tyr or D- or L-Nal or Ain;

B.sup.2 is D- or L-Trp;

B.sup.3 is D- or L-Lys or Hly, Achxa, Amf, Aec, Apc, Aes, or Aps;

B.sup.4 is Thr, Ser, Val, Phe, Ile, Abu, Nle, Leu, Nva or Aib;

C.sup.4 is an L-amino acid having a sidechain comprising a mercapto group;

A.sup.4 is a lipophilic D-amino acid or a lipophilic L-(.alpha.-N-alkyl)amino acid or L-proline;

wherein A.sup.4 and C.sup.4 are covalently linked through an amino terminus of A.sup.4 and a carboxyl terminus of C.sup.4 ; and

b) a polyvalent linker covalently linked to each peptide.

5. The multimer of claim 4, wherein the linker is selected from the group consisting of bis-succinimidylmethylether, 4-(2,2-dimethylacetyl)benzoic acid, N-[2-(N',N'-bis(2-succinimidoethyl)aminoethyl)]-N.sup.6,N.sup.9 -bis(2-methyl-2-mercaptopropyl)-6,9-diazanonanamide, tris(succinimidylethyl)amine, bis-succinimidohexane, and 4-(O--CH.sub.2 CO-Gly-Gly-Cys.amide)-2-methylpropiophenone.

6. A kit for preparing a radiopharmaceutical preparation, said kit comprising a sealed vial containing a predetermined quantity of the peptide of claim 1.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Colorcon
Teva
Cipla
AstraZeneca
Novartis
Cantor Fitzgerald
Fuji
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot